Arylsulfonamide agonists of the human beta 3 adrenergic receptor for the treatment of obesity.

被引：0

作者：

Weber, AE ^{[1
]}

Mathvink, RJ ^{[1
]}

Hutchins, JE ^{[1
]}

Perkins, LM ^{[1
]}

Parmee, ER ^{[1
]}

Ok, HO ^{[1
]}

Candelore, MR ^{[1
]}

Vicario, PP ^{[1
]}

Cascieri, MA ^{[1
]}

Strader, CD ^{[1
]}

Hom, GJ ^{[1
]}

Forrest, MJ ^{[1
]}

MacIntyre, DE ^{[1
]}

Alvaro, RF ^{[1
]}

Kao, J ^{[1
]}

Wyvratt, MJ ^{[1
]}

Fisher, MH ^{[1
]}

机构：

[1] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 213卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：168 / MEDI

页数：1

共 50 条

[1] Development of β3 adrenergic receptor agonists for the treatment of obesity.
Weber, AE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U27 - U27
[2] β3 receptor agonists for the treatment of obesity.
Shuker, AJ
Bell, MG
Bloomquist, W
Calligaro, DO
Cohen, ML
Crowell, TA
Cusick, TS
Droste, CA
Evrard, DA
Hahn, PJ
Heiman, ML
Jesudason, CD
Jones, CD
Kim, G
Kriauciunas, AV
Matthews, DP
McDonald, JH
Neel, DA
Palkowitz, AD
Peters, MK
Rito, CJ
Siegel, MG
Stephens, TW
Winter, MA
Dananberg, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1202 - U1202
[3] Selective beta 3 receptor agonists and beta adrenergic modulators for the treatment of obesity and NIDDM.
Shuker, AJ
Siegel, MG
Bell, MG
Bryant, RD
Crowell, TA
Cusick, TS
Droste, CA
Fisher, JW
Gritton, WH
Hahn, PJ
Jesudason, CD
Jones, CD
Kaldor, SW
Kim, G
Kriauciunas, AV
Matthews, DP
McDonald, JH
Neel, DA
Palkowitz, AD
Pennington, PA
Peters, MK
Rito, CJ
Trankle, WG
Stephens, TW
Winter, MA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 261 - MEDI
[4] Selective β adrenergic modulators for the treatment of obesity.
Jesudason, CD
Bell, MG
Crowell, TA
Droste, CA
Jones, CD
Kim, G
Matthews, DP
Neel, DA
Rito, CJ
Shuker, AJ
Winter, MA
Bryant, RD
Fisher, JW
Peters, MK
Trankle, WG
Helman, ML
Kriauciunas, AV
Tinsley, FC
Dananberg, J
Miller, JW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U589 - U589
[5] β1-adrenergic receptor polymorphisms and obesity.
Humma, LM
Puckett, BJ
Lejeune, BL
McNamara, DM
Pepine, CJ
Johnson, JA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P63 - P63
[6] Progress towards selective, full-agonists of the human beta(3)-adrenergic receptor
Dow, RL
Chou, TT
Olson, TV
Schneider, SR
Hargrove, DM
Kreutter, DK
Yee, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 180 - MEDI
[7] Indazoles as selective 5-HT2C receptor agonists for the treatment of obesity.
Dawson, CE
Adams, DR
Bentley, JM
Benwell, K
Bickerdike, MJ
Cliffe, IA
Duncton, MAJ
Hamlyn, RJ
Kennett, GA
Knight, T
Malcolm, C
Misra, A
Roffey, JR
Vickers, S
Dourish, CT
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
[8] Obesity and diabetes and the beta-3 adrenergic receptor
Danforth, E
HimmsHagen, J
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) : 362 - 365
[9] THE BETA(3)-ADRENERGIC RECEPTOR - A CAUSE AND CURE OF OBESITY
ARNER, P
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (06): : 382 - 383
[10] Design and synthesis of potent, selective melanocortin subtype-4 receptor agonists for the treatment of obesity.
Xi, N
Adams, J
Bo, YX
Chen, N
Croghan, M
Doherty, E
Han, NH
Liao, HY
Liu, QY
Kelly, M
Norman, M
Stec, M
Tamayo, N
Xu, SM
Cheetham, J
Smith, D
Hsieh, F
Bannon, T
Hale, C
Baumgartner, J
Fotsch, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U942 - U942

← 1 2 3 4 5 →